SEC Form 5 · accession 0001209191-18-007565
Conatus Pharmaceuticals Inc. · CNAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michelle L Vandertie
Officer — Vice President, Finance
Period of report
Dec 31, 2017
Accepted (ET)
Feb 5, 2018 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001383701
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 30, 2017 | G | 2,165 | $0.00 | D | 2,813 | I | See footnote. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Bona fide gift to child.
- F2Held by family trust of which the Reporting Person is a trustee.